3.64
price down icon4.21%   -0.16
after-market アフターアワーズ: 3.71 0.07 +1.92%
loading

Immix Biopharma Inc (IMMX) 最新ニュース

pulisher
Nov 03, 2025

Immix Biopharma : Presentation (IMMX Corporate presentation November 2025) - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

What analysts say about Immix Biopharma Inc stockTechnical Resistance Breaks & Affordable Portfolio Growth - earlytimes.in

Nov 03, 2025
pulisher
Nov 03, 2025

Can trapped investors hope for a rebound in Immix Biopharma Inc.Bear Alert & Daily Stock Trend Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Immix Biopharma Inc. stock valuations compare to rivals2025 Price Targets & AI Forecast Swing Trade Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to manage a losing position in Immix Biopharma Inc.Trade Exit Summary & Capital Efficient Trading Techniques - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Immix Biopharma to present NXC-201 trial data for AL amyloidosis at ASH - Investing.com

Nov 03, 2025
pulisher
Nov 03, 2025

Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025 - Investing News Network

Nov 03, 2025
pulisher
Nov 03, 2025

Immix Biopharma (IMMX) ASH 2025 oral to feature NEXICART-2 first 20-patient data on Dec 7 - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

How Immix Biopharma Inc. stock reacts to bond yieldsGap Up & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Immix Biopharma Inc (IMMX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com

Nov 03, 2025
pulisher
Nov 03, 2025

Immix Biopharma Inc. stock volume spike explainedJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What the charts say about Immix Biopharma Inc. today2025 Analyst Calls & Safe Entry Point Identification - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Immix Biopharma Inc. stock appeals to dividend seekersIPO Watch & Reliable Entry Point Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Immix Biopharma Inc. stock sustain high P E ratiosEarnings Miss & Daily Entry Point Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Immix Biopharma Inc. stock trendline breakdownTrade Analysis Report & Daily Volume Surge Signals - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Comparing Immix Biopharma Inc. in custom built stock radarsQuarterly Portfolio Report & Reliable Breakout Forecasts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Risk adjusted return profile for Immix Biopharma Inc. analyzedMarket Performance Recap & Risk Controlled Stock Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Immix Biopharma Inc. stock a smart buy before Fed meeting2025 Market Outlook & Daily Stock Momentum Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Immix Biopharma Inc. still worth holding after the dip2025 Volume Leaders & Technical Confirmation Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Immix Biopharma Inc. see short term momentum2025 Major Catalysts & Capital Protection Trading Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Immix Biopharma (NASDAQ:IMMX) Trading Down 1.3%Time to Sell? - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

Momentum divergence signals in Immix Biopharma Inc. chartJuly 2025 Decliners & Daily Stock Trend Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis - TipRanks

Oct 31, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
大文字化:     |  ボリューム (24 時間):